Clinical Trials Directory

Trials / Completed

CompletedNCT04699916

EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia

EEG-based Protocol to Guide Deep Sedation Decreases the Days of Mechanical Ventilation in Patients With SARS-CoV-2 Pneumonia: Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Chile · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Deep sedation in patients with COVID-19 may be challenging in many aspects. The use of an EEG-based protocol to guide deep sedation may be useful in this particular population, considering their unusually high sedation requirements. In the present trial, we aim to evaluate an EEG-based protocol to guide deep sedation in patients with COVID19, using to EEG derived parameters that are displayed in the BIS monitor: Suppression Rate and Spectral Edge Frequency. The protocol is designed to both minimize the suppression rate along with maintaining a spectral edge frequency over 10 Hz. The use of this protocol may reduce the amount of sedatives administered and, therefore, diminish the time needed for the weaning process.

Conditions

Interventions

TypeNameDescription
OTHEREEG based protocol for deep sedationProtocol established to guide sedation drug dosification to maintain the patient with a Suppression Rate (SR) less than 1% and a Spectral Edge Frequency 95 over 10 Hz

Timeline

Start date
2021-01-04
Primary completion
2021-05-23
Completion
2021-09-23
First posted
2021-01-07
Last updated
2021-09-24

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT04699916. Inclusion in this directory is not an endorsement.